Acute Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis to Minimize Ocular Sequelae

American Journal of Ophthalmology

Volumn 147, Issue 6, 2009, Pages 949-951

  Tseng, Scheffer C G ^a  

^a OCULAR SURFACE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BLINDNESS; DRUG MEGADOSE; EDITORIAL; HUMAN; INFECTION RISK; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VISUAL IMPAIRMENT;

ACUTE DISEASE; EPIDERMAL NECROLYSIS, TOXIC; EYE DISEASES; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; PULSE THERAPY, DRUG; STEVENS-JOHNSON SYNDROME;

EID: 65649150764     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.02.011     Document Type: Editorial

References (19)

1. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 (1994) 1272-1285
2. Di Pascuale M.A., Espana E.M., Liu D.T., et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112 (2005) 904-912
3. Fritsch P.O., and Ruiz-Maldonado R. Stevens-Johnson syndrome-toxic Epidermal Necrolysis. In: Freedberg I.M., Eisen A.Z., Wolff K., et al. (Eds). Fitzpatrick's Dermatology in General Medicine. 5th ed. (1999), McGraw-Hill, New York, New York 644-654
4. Araki Y., Sotozono C., and Inatomi T. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 147 (2009) 1004-1011
5. Bastuji-Garin S., Rzany B., and Stern R.S. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129 (1993) 92-96
6. Bachot N., and Roujeau J.C. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 4 (2003) 561-572
7. Assier H., Bastuji-Garin S., Revuz J., and Roujeau J.C. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 131 (1995) 539-543
8. Cote B., Wechsler J., and Bastuji-Garin S. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol 131 (1995) 1268-1272
9. Auquier-Dunant A., Mockenhaupt M., and Naldi L. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138 (2002) 1019-1024
10. Paquet P., and Pierard G.E. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 19 (1997) 127-132
11. Pichler W.J. Delayed drug hypersensitivity reactions. Ann Intern Med 139 (2003) 683-693
12. Neuman M., and Nicar M. Apoptosis in ibuprofen-induced Stevens-Johnson syndrome. Transl Res 149 (2007) 254-259
13. Gregory D.G. The ophthalmologic management of acute Stevens-Johnson syndrome. Ocul Surf 6 (2008) 87-95
14. Park W.C., and Tseng S.C.G. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci 41 (2000) 2906-2914
15. Bauer D., Wasmuth S., Hermans P., et al. On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation. Exp Eye Res 85 (2007) 335-345
16. Heiligenhaus A., Meller D., Meller D., Steuhl K.-P., and Tseng S.C.G. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest Ophthalmol Vis Sci 42 (2001) 1969-1974
17. Li W., He H., Kawakita T., Espana E.M., and Tseng S.C.G. Amniotic membrane induces apoptosis of interferon-gamma activited macrophages in vitro. Exp Eye Res 82 (2006) 282-292
18. Ueta M., Kweon M.N., Sano Y., et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol 129 (2002) 464-470
19. He H., Li W., Chen S.Y., et al. Suppression of activation and induction apoptosis in RAW264.7 cells by amniotic membrane extract. Invest Ophthalmol Vis Sci 49 (2008) 4468-4475